AI
COGT icon

Atom Investors’s Cogent Biosciences COGT Stock Holding History

Atom Investors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.37M Buy
87,676
+69,568
+384% +$2.57M 0.24% 133
2025
Q4 		$643K Buy
+18,108
New +$509K 0.05% 368
2025
Q1 		– Sell
-14,277
Closed -$111K – 530
2024
Q4 		$111K Buy
+14,277
New +$142K 0.01% 447
2024
Q3 		– Sell
-23,174
Closed -$195K – 487
2024
Q2 		$195K Sell
23,174
-17,308
-43% -$131K 0.02% 429
2024
Q1 		$272K Sell
40,482
-62,734
-61% -$388K 0.03% 427
2023
Q4 		$607K Buy
103,216
+65,818
+176% +$504K 0.11% 247
2023
Q3 		$365K Buy
37,398
+24,104
+181% +$286K 0.08% 287
2023
Q2 		$157K Sell
13,294
-10,152
-43% -$116K 0.06% 257
2023
Q1 		$253K Sell
23,446
-60,898
-72% -$779K 0.14% 173
2022
Q4 		$975K Buy
84,344
+47,382
+128% +$587K 0.49% 54
2022
Q3 		$551K Sell
36,962
-42,799
-54% -$587K 0.19% 142
2022
Q2 		$719K Sell
79,761
-35,667
-31% -$243K 0.31% 92
2022
Q1 		$865K Buy
115,428
+54,068
+88% +$377K 0.4% 59
2021
Q4 		$526K Buy
+61,360
New +$533K 0.09% 159

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Atom Investors's COGT Position: Q1 2026 in Review

Atom Investors increased its Cogent Biosciences (COGT) stake by 384% in Q1 2026, buying an estimated $2.57M and bringing the position to 87,676 shares worth $3.37M. The position accounts for 0.24% of the portfolio, ranked #133.

Atom Investors first reported a position in COGT in Q4 2021 and has held it in 14 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Atom Investors held 87,676 shares of Cogent Biosciences worth $3.37M as of Q1 2026.
  • Atom Investors bought 69,568 Cogent Biosciences shares in Q1 2026, an estimated $2.57M.
  • Cogent Biosciences made up 0.24% of Atom Investors's portfolio in Q1 2026, its #133 holding.
  • Atom Investors first reported a position in Cogent Biosciences in Q4 2021 and has held it in 14 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.